BR0308231A - Composições farmacêuticas em grânulos de liberação imediata e um processo contìnuo para a obtenção das mesmas - Google Patents

Composições farmacêuticas em grânulos de liberação imediata e um processo contìnuo para a obtenção das mesmas

Info

Publication number
BR0308231A
BR0308231A BR0308231-8A BR0308231A BR0308231A BR 0308231 A BR0308231 A BR 0308231A BR 0308231 A BR0308231 A BR 0308231A BR 0308231 A BR0308231 A BR 0308231A
Authority
BR
Brazil
Prior art keywords
immediate release
pharmaceutical compositions
continuous process
weight
release granules
Prior art date
Application number
BR0308231-8A
Other languages
English (en)
Inventor
Jean-Paul Remon
Kris Vervaet
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Publication of BR0308231A publication Critical patent/BR0308231A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

"COMPOSIçõES FARMACêUTICAS EM GRâNULOS DE LIBERAçãO IMEDIATA E UM PROCESSO CONTìNUO PARA A OBTENçãO DAS MESMAS". A presente invenção refere-se a uma composição farmacêutica em grânulos de liberação imediata que compreende (I) pelo menos uma droga que pode ser classificada como classe II ou Classe IV do Biopharmaceutical Classification System, em que a dita droga constitui pelo menos aproximadamente 0,5 % em peso e até aproximadamente 20 % em peso da composição, a dita composição compreendendo ainda (ii) um primeiro excipiente selecionado do grupo que consiste em: mesclas de uma celulose microcristalina e um polímero inflável em quantidades respectivas tal que a proporção em peso do dito polímero para a celulose microcristalina na mescla seja acima de aproximadamente 2 : 100 e até aproximadamente 30 : 100, - um ou mais compostos que contêm dextrina selecionados do grupo que consiste em maltodextrinas, ciclodextrinas e derivado das mesmas e - misturas dos ditos compostos que contêm dextrina e das ditas mesclas e (iii) uma quantidade para umidificação de um segundo excipiente que é um composto para umidificação não-aquoso ou um composto que pode ser fundido e que compreende uma fração sólida e opcionalmente uma fração líquida.
BR0308231-8A 2002-03-06 2003-03-05 Composições farmacêuticas em grânulos de liberação imediata e um processo contìnuo para a obtenção das mesmas BR0308231A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0205253.8A GB0205253D0 (en) 2002-03-06 2002-03-06 Immediate release pharmaceutical granule compositions and a continuous process for making them
PCT/BE2003/000040 WO2003074031A1 (en) 2002-03-06 2003-03-05 Immediate release pharmaceutical granule compositions and a continuous process for making them

Publications (1)

Publication Number Publication Date
BR0308231A true BR0308231A (pt) 2004-12-28

Family

ID=9932403

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0308231-8A BR0308231A (pt) 2002-03-06 2003-03-05 Composições farmacêuticas em grânulos de liberação imediata e um processo contìnuo para a obtenção das mesmas

Country Status (21)

Country Link
US (4) US20050058705A1 (pt)
EP (1) EP1480622B1 (pt)
KR (1) KR20040091099A (pt)
CN (1) CN1638738B (pt)
AR (1) AR038880A1 (pt)
AT (1) ATE418327T1 (pt)
AU (1) AU2003215449B2 (pt)
BR (1) BR0308231A (pt)
CA (1) CA2477890C (pt)
DE (1) DE60325461D1 (pt)
DK (1) DK1480622T3 (pt)
ES (1) ES2318147T3 (pt)
GB (1) GB0205253D0 (pt)
MX (1) MXPA04008543A (pt)
MY (1) MY138752A (pt)
PL (1) PL208133B1 (pt)
PT (1) PT1480622E (pt)
SA (1) SA03240089B1 (pt)
TW (1) TWI296198B (pt)
WO (1) WO2003074031A1 (pt)
ZA (1) ZA200407998B (pt)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them
WO2004100857A2 (en) * 2003-05-07 2004-11-25 Akina, Inc. Highly plastic granules for making fast melting tablets
US8377952B2 (en) * 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US7888412B2 (en) 2004-03-26 2011-02-15 Board Of Trustees Of The University Of Alabama Polymer dissolution and blend formation in ionic liquids
US7550520B2 (en) 2005-05-31 2009-06-23 The University Of Alabama Method of preparing high orientation nanoparticle-containing sheets or films using ionic liquids, and the sheets or films produced thereby
US8883193B2 (en) 2005-06-29 2014-11-11 The University Of Alabama Cellulosic biocomposites as molecular scaffolds for nano-architectures
EP1745775B1 (en) * 2005-07-19 2008-05-28 Ethypharm Gastroretentive formulations and manufacturing process thereof.
GB0612695D0 (en) * 2006-06-27 2006-08-09 Univ Gent Process for preparing a solid dosage form
RU2454220C2 (ru) 2006-08-16 2012-06-27 Новартис Аг Способ получения твердых дисперсий высококристаллических терапевтических соединений
WO2008021666A2 (en) * 2006-08-18 2008-02-21 Morton Grove Pharmaceuticals, Inc. Stable liquid levetiracetam compositions and methods
BRPI0720492A2 (pt) * 2006-12-19 2014-02-04 Schering Plough Ltd Formulações efervescentes de florfenicol para adição em sistemas de água potável
MX2009011642A (es) * 2007-04-27 2010-01-29 Schering Plough Ltd Compuestos y metodos para potenciar la solubilidad de florfenicol y antibioticos estructuralmente relacionados utilizando ciclodextrinas.
WO2009105236A1 (en) 2008-02-19 2009-08-27 The Board Of Trustees Of The University Of Alabama Ionic liquid systems for the processing of biomass, their components and/or derivatives, and mixtures thereof
JP5519639B2 (ja) * 2008-04-28 2014-06-11 フォーマック ファーマシューティカルズ ナムローゼ フェンノートシャップ 秩序化したメソポーラスシリカ材料
FR2935084B1 (fr) * 2008-08-19 2011-05-06 Pancosma Sa Pour L Ind Des Produits Biochimiques Additif pour l'alimentation animale et son procede de preparation
WO2010078300A1 (en) 2008-12-29 2010-07-08 The Board Of Trustees Of The University Of Alabama Dual functioning ionic liquids and salts thereof
WO2010141470A2 (en) 2009-06-01 2010-12-09 The Board Of Trustees Of The University Of Alabama Process for forming films, fibers, and beads from chitinous biomass
WO2011011322A1 (en) 2009-07-24 2011-01-27 The Board Of Trustees Of The University Of Alabama Conductive composites prepared using ionic liquids
BRPI1002023A2 (pt) 2010-03-01 2011-10-25 Nanocore Biotecnologia S A forma farmacêutica sólida de dissolução rápida para tratamento de infecções bacterianas
CN101843586B (zh) * 2010-04-29 2012-05-23 山东迅达康兽药有限公司 一种含有氟苯尼考的可溶于水的微粉及其制备方法
CN102178068B (zh) * 2010-07-06 2013-07-31 新疆农业大学 一种饲料添加剂的使用方法
US9394375B2 (en) 2011-03-25 2016-07-19 Board Of Trustees Of The University Of Alabama Compositions containing recyclable ionic liquids for use in biomass processing
WO2012151237A1 (en) * 2011-05-02 2012-11-08 Aptalis Pharmatech, Inc. Rapid dissolve tablet compositions for vaginal administration
EP2537518A1 (en) * 2011-06-24 2012-12-26 Elanco Animal Health Ireland Limited Fast dissolving azaperone granulate formulation
EP2942052A4 (en) 2013-01-07 2016-06-08 Sam A Pharm Co Ltd NEW FORMULATION OF RAPID DISSOLUTION PELLETS WITH ENHANCED SOLUBILITY
BR102013020508B1 (pt) * 2013-08-12 2021-01-12 Ems S/A. Forma de dosagem que compreende um inibidor de esteroide 5-alfa-redutase e um bloqueador alfa, processo para a preparaçãode uma forma de dosagem e uso da forma de dosagem
US10100131B2 (en) 2014-08-27 2018-10-16 The Board Of Trustees Of The University Of Alabama Chemical pulping of chitinous biomass for chitin
US10982381B2 (en) 2014-10-06 2021-04-20 Natural Fiber Welding, Inc. Methods, processes, and apparatuses for producing welded substrates
US10011931B2 (en) 2014-10-06 2018-07-03 Natural Fiber Welding, Inc. Methods, processes, and apparatuses for producing dyed and welded substrates
FI3258920T3 (fi) 2015-02-17 2023-06-28 Univ Gent Juomavesilääkkeenä käytettäväksi soveltuva kiinteä farmaseuttinen annosmuoto
WO2017136745A1 (en) * 2016-02-05 2017-08-10 Entrega Inc. Oral dosage form with drying agent for delivery of active agent
EP3423063A4 (en) * 2016-03-04 2019-11-06 Embera Neurotherapeutics, Inc COMPOSITIONS AND METHODS FOR TREATING SEARCH OR SUBSTANCE ABUSE MISTAKES
MX2018010421A (es) 2016-03-25 2019-05-20 Natural Fiber Welding Inc Metodos, procesos y aparatos para producir sustratos soldados.
JP7114484B2 (ja) 2016-05-03 2022-08-08 ナチュラル ファイバー ウェルディング インコーポレーテッド 染色及び溶着された基材を製造するための方法、プロセス、及び装置
CN108210501B (zh) * 2016-12-14 2019-03-08 中国人民解放军军事医学科学院毒物药物研究所 一种磺酰脲类药物的注射用药物组合物及其制备方法
US10927191B2 (en) 2017-01-06 2021-02-23 The Board Of Trustees Of The University Of Alabama Coagulation of chitin from ionic liquid solutions using kosmotropic salts
BR112019018700A2 (pt) 2017-03-10 2020-04-07 Embera Neurotherapeutics Inc composições farmacêuticas e seus usos
WO2018236445A2 (en) 2017-03-24 2018-12-27 The Board Of Trustees Of The University Of Alabama Metal particle-chitin composite materials and methods of making thereof
TWI829660B (zh) 2017-11-11 2024-01-21 美商天然纖維焊接股份有限公司 紗與熔接紗
CA3111385A1 (en) * 2018-09-06 2020-03-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Sustained-release injectable antibiotical formulation
CN114532451B (zh) * 2022-02-28 2023-06-02 安徽科技学院 一种促进肉羊育肥的中药组方添加剂及制备方法
CN115252821A (zh) * 2022-08-10 2022-11-01 四川科宏达集团有限责任公司 一种可溶性氟苯尼考粉的制备方法
CN116019771A (zh) * 2022-09-09 2023-04-28 沈阳伟嘉生物技术有限公司 一种氟苯尼考可混饮无定形固体分散体制剂及其制备方法和用途

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639637A (en) * 1968-04-23 1972-02-01 Richardson Merrell Inc Water dispersible diethylstilbestrol compositions
US4235892A (en) * 1979-02-05 1980-11-25 Schering Corporation, Patent Dept. 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
FR2570390B1 (fr) * 1984-09-14 1987-11-27 Glaxo Group Ltd Nouveaux composes antibiotiques et procede de preparation
DE3440288C2 (de) 1984-11-05 1987-03-12 Gergely, Gerhard, Dr.-Ing., Wien Pharmazeutische Zubereitung mit einem Gehalt an Ibuprofen sowie Verfahren zu ihrer Herstellung
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
FR2634376B1 (fr) 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
GB8913889D0 (en) 1989-06-16 1989-08-02 May & Baker Ltd New compositions of matter
IT1246188B (it) * 1990-07-27 1994-11-16 Resa Farma Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
US5082863A (en) * 1990-08-29 1992-01-21 Schering Corporation Pharmaceutical composition of florfenicol
AU671811B2 (en) * 1991-12-18 1996-09-12 Warner-Lambert Company A process for the preparation of a solid dispersion
US5362860A (en) * 1993-02-01 1994-11-08 Warner-Lambert Company Neutral stabilization complex for CI-979 HCl, a cognition activator
BE1006990A5 (nl) * 1993-04-22 1995-02-07 Univ Gent Werkwijze en samenstelling om een aktief bestanddeel in een vaste toedieningsvorm te brengen.
US5646131A (en) * 1994-02-22 1997-07-08 The Arab Company For Drug Industries And Medical Applicances (Acdima) Method for solubilizing drugs using cyclodextrins and carboxylic acids
HN1998000115A (es) * 1997-08-21 1999-06-02 Warner Lambert Co Formas de dosificación farmacéuticas sólidas
US6153206A (en) * 1997-08-27 2000-11-28 Revlon Consumer Products Corporation Cosmetic compositions
CA2301883A1 (en) 1997-09-11 1999-03-18 Nycomed Danmark A/S Modified release multiple-units compositions of non-steroid anti-inflammatory drug substances (nsaids)
US6010719A (en) * 1997-09-16 2000-01-04 Universiteit Gent Freeze-dried disintegrating tablets
US6211185B1 (en) * 1999-05-05 2001-04-03 Veterinary Pharmacy Corporation Concentrate comprising a sulfonamide in solution, a 2,4-diaminopyrimidine in stable suspension within said solution, and a suspending agent
US20010046526A1 (en) * 2000-04-19 2001-11-29 C-Quest Treatment of fungal infections
AU2001257511A1 (en) * 2000-05-03 2001-11-12 Joe D'silva Process and device for producing liquid dosage formulations
AU2002212200A1 (en) * 2000-08-31 2002-03-13 Universiteit Gent Controlled release pharmaceutical pellet compositions for reducing side effects of drugs
US6663897B2 (en) * 2001-02-06 2003-12-16 Dsm Ip Assets B.V. Oral itraconazole formulations and methods of making the same
MXPA04007428A (es) * 2002-02-01 2004-10-11 Pfizer Prod Inc Formas de dosificacion de liberacion inmediata que contienen dispersiones de farmaco solido.
GB0205253D0 (en) * 2002-03-06 2002-04-17 Univ Gent Immediate release pharmaceutical granule compositions and a continuous process for making them

Also Published As

Publication number Publication date
PL208133B1 (pl) 2011-03-31
CA2477890A1 (en) 2003-09-12
HK1078006A1 (en) 2006-03-03
ES2318147T3 (es) 2009-05-01
DK1480622T3 (da) 2009-02-16
EP1480622A1 (en) 2004-12-01
KR20040091099A (ko) 2004-10-27
US8349366B2 (en) 2013-01-08
DE60325461D1 (de) 2009-02-05
TWI296198B (en) 2008-05-01
PT1480622E (pt) 2009-03-06
CN1638738B (zh) 2012-06-06
MXPA04008543A (es) 2004-12-06
ATE418327T1 (de) 2009-01-15
US20110027377A1 (en) 2011-02-03
CA2477890C (en) 2011-05-10
CN1638738A (zh) 2005-07-13
TW200305446A (en) 2003-11-01
WO2003074031A1 (en) 2003-09-12
US8337897B2 (en) 2012-12-25
AU2003215449A1 (en) 2003-09-16
SA03240089B1 (ar) 2008-07-12
MY138752A (en) 2009-07-31
GB0205253D0 (en) 2002-04-17
PL372579A1 (en) 2005-07-25
EP1480622B1 (en) 2008-12-24
US20050058705A1 (en) 2005-03-17
US20070009592A1 (en) 2007-01-11
AR038880A1 (es) 2005-02-02
AU2003215449B2 (en) 2007-07-26
ZA200407998B (en) 2006-06-28
US20110008454A1 (en) 2011-01-13

Similar Documents

Publication Publication Date Title
BR0308231A (pt) Composições farmacêuticas em grânulos de liberação imediata e um processo contìnuo para a obtenção das mesmas
Rodrigues Filho et al. Characterization of methylcellulose produced from sugar cane bagasse cellulose: Crystallinity and thermal properties
Sentellas et al. Aclidinium bromide, a new, long-acting, inhaled muscarinic antagonist: in vitro plasma inactivation and pharmacological activity of its main metabolites
Ni et al. Use of pure t-butanol as a solvent for freeze-drying: a case study
BR0116385A (pt) Composto, composição farmacêutica, embalagem, métodos para alterar a atividade transdutora de sinal de um receptor de gabaa, para tratar ansiedade, depressão, um distúrbio do sono, esquizofrenia, distúrbio do déficit de atenção hiperatividade ou para a memória, para demonstrar a presença de um receptor de gabaa em uma amostra de célula ou tecido e em uma seção de tecido uso de um composto, e, processo para preparar um composto
UA128703C2 (uk) Фармацевтична композиція, яка містить інгібітор parp
NO20071853L (no) Farmasoytisk sammensetning inneholdende en fast dispersjon med en polymermatriks inneholdende en jevn polydekstrosefase og en jevn fase av en polymer forskjellig fra polydekstrose.
PT2376506E (pt) Composição líquida contendo derivado de triamida fosfórica ou tiofosfórica e sua utilização
BR0215175A (pt) Métodos para a granulação úmida de azitromicina
BR0103844A (pt) Sistema de aditivo polimérico múltiplo, processo para produzir o mesmo, composição polimérica, e, processo para produzir a mesma
HRP20050205A2 (en) Benzensulfonate of 4-fluoro-2-cyanopyrrolidine derivative
BR0208374A (pt) Composição de diacetal, agente de nucleação de poliolefina compreendendo a composição de diacetal, composições de resina poliolefìnica contendo a composição diacetal, método para fabricação da composição de resina, e moldagens
BRPI0409049A (pt) métodos de preparação de um composto, composição e composição cristalina
Trivedi et al. In silico and in vitro studies to elucidate the role of 1HYN and 1QKI activity in BPA induced toxicity and its amelioration by Gallic acid
BRPI0417001A (pt) composto, composição farmacêutica, e, utilização de um composto
Janaki et al. Anti-inflammatory activity of Aglaia roxburghiana var. beddomei extract and triterpenes roxburghiadiol A and B
BR0318242A (pt) derivados de azabiciclo hexano substituìdo como antagonistas de receptores muscarìnicos e processo para sua preparação
CN106668016B (zh) 阿齐沙坦和苯磺酸氨氯地平组合物的固体制剂及其制备方法
BRPI0713439A2 (pt) derivados aminados de b-homoandrostanos e b-heteroandrostanos
BRPI0212195B1 (pt) Composições contendo pectina e ácido ascórbico
JPH0912592A (ja) リグナン系化合物
BR0213432A (pt) Processo para a preparação de grânulos de detergente
van Rensburg et al. A new model for the study of high-K+-induced preconditioning in cultured neurones: Role of N-methyl-d-aspartate and α7-nicotinic acetylcholine receptors
CN107157943B (zh) 一种托匹司他制剂及其制备方法
Lian et al. The application with tetramethyl pyrazine for antithrombogenicity improvement on silk fibroin surface

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B15K Others concerning applications: alteration of classification

Free format text: PARA.INT.CI. A61K 9/16, A61P 11/00, A61P 29/00

Ipc: A61K 9/16 (2011.01), A61P 11/00 (2011.01), A61P 29

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time